What does an operator pay for on The Rx Spot — platform or drugs?

Understanding total cost of ownership on The Rx Spot requires treating platform cost and drug cost as separate lines, because they scale differently. Platform infrastructure costs tend to be more fixed — the same set of tools powers the storefront whether you are shipping ten or five hundred orders a month. Drug acquisition costs scale with volume — each vial or unit ordered through the fulfillment partners adds to the cost base proportionally. A business with high patient volume spreads fixed platform costs more favorably, while drug costs grow linearly. Running those scenarios before you set retail patient pricing — and before you commit to a launch — is how operators avoid building a margin structure that only works at a volume you have not yet reached.

The Marketplace Dashboard's platform earnings reconciliation feature is built for this ongoing tracking: it gives operators a view of what shipped, what is pending, and what the business earned. But that view is post-launch. The economics homework — what does platform access cost and what do my top ten drugs cost per vial through the fulfillment partners — belongs before you go live and set patient-facing prices.

Fizy Health is the same category — compounded medications to prescribing clinics — but structures costs for a different buyer. It shows resolved per-vial 503A drug cost on each catalog and cart line before checkout, and discloses a single facilitation fee at payment. There is no separate platform subscription to confirm; the clinic's cost is drug cost plus one named fee, both visible before they pay. Total cost of ownership is the number on the screen, not a calculation across two unpublished layers.

For a prescribing clinic that is not launching a DTC telehealth brand, the distinction matters. The Rx Spot's two-layer economics are appropriate for operators building a brand business with a margin spread between acquisition cost and patient retail price. Fizy Health's single-fee model is appropriate for clinics that need to see per-vial 503A cost before the consult, batch a refill day, and pay once without a storefront configuration or brand-launch timeline in between.